| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |